Clinical Trial Update: Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating immunotherapy in combination with chemotherapy for HER2-negative inflammatory breast cancer; the study is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Inflammatory Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING